North American crotalid venom toxins

North American crotalid venom toxins are a complex mixture of bioactive proteins and peptides produced by pit vipers, including rattlesnakes (Crotalus and Sistrurus), copperheads, and cottonmouths (Agkistrodon) (StatPearls, 2023). These toxins primarily consist of snake venom metalloproteinases (SVMPs), snake venom serine proteases (SVSPs), phospholipases A2 (PLA2), and disintegrins (Toxins, 2016; Journal of Toxicology, 2012). Biologically, they function to immobilize and digest prey by inducing systemic effects such as coagulopathy, hemorrhage, and hypotension, as well as local effects like tissue necrosis and edema (StatPearls, 2023). In a clinical context, these toxins are the primary targets for antivenom therapies, which utilize purified antibody fragments to bind and neutralize the venom components (FDA: CroFab Label, 2018; FDA: Anavip Label, 2018). Understanding the specific composition of these toxins is crucial for managing snakebite envenomation, as the clinical presentation varies significantly between species (StatPearls, 2023). Therapeutic intervention focuses on preventing the toxins from reaching their physiological targets, such as fibrinogen, platelets, and vascular endothelium (FDA: CroFab Label, 2018).

Other names

Crotalinae venomPit viper venomRattlesnake venom toxinsCrotalid toxins

Neutralization of venom components through antibody-antigen binding, which prevents the toxins from interacting with host physiological targets and facilitates their clearance from systemic circulation (FDA: CroFab Label, 2018; FDA: Anavip Label, 2018).